Lynparza

AstraZeneca Pharma India gets DCGI nod to market cancer drug in India

New Delhi, August 18, 2018: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets…

6 years ago